Anavex Life Sciences Corp Receivables Turnover Ratio (AVXL), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Anavex Life Sciences Corp   (NASDAQ: AVXL)
 

Anavex Life Sciences Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Anavex Life Sciences Corp 's ability to collect accounts receivable sequentially worsen to 1.71, indicating more challenging environment then in the second quarter 2026, but still, it is a far cry from any concerns. Anavex Life Sciences 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 213 days, from 106 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Anavex Life Sciences Corp achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Anavex Life Sciences Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AVXL Receivables Turnover Ratio (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change - - - -45.11 % -
Receivable Turnover Ratio (TTM) 1.71 3.43 - - -
AVXL's Total Ranking # # # # #
Accounts Receivable average collection period days 213 107 - - -
Seq. Receivable Change 0 % - - - -
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





AVXL Company Profile • Back to AVXL Efficiency Comparisons • Compare AVXL Receivables Turnover Ratio to its Competitors

Financial Statements
Anavex Life Sciences 's Accounts Receivable $ 1 Millions Visit AVXL's Balance sheet
Anavex Life Sciences 's Sales TTM $ 1 Millions Visit AVXL's Income Statement
Sources of AVXL's Revenues Visit AVXL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AVXL's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AVXL's Growth Rates AVXL's Roa AVXL's Inventory Turnover Ratio AVXL's Dividend Comparisons
AVXL's Profitability Ratios AVXL's Roi AVXL's Asset Turnover Ratio AVXL's Dividend Growth
AVXL's Valuation Ratios AVXL's Roe AVXL's Financial Strength Ratios AVXL's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Arbutus Biopharma Corp  2.35 $ 181.720  Millions$ 77.420  Millions
Tg Therapeutics Inc   2.34 $ 799.536  Millions$ 341.156  Millions
Abcellera Biologics Inc   2.30 $ 66.174  Millions$ 28.812  Millions
Cumberland Pharmaceuticals Inc   2.27 $ 31.269  Millions$ 13.764  Millions
Co diagnostics Inc   2.14 $ 0.721  Millions$ 0.337  Millions
Profound Medical Corp   2.14 $ 19.086  Millions$ 8.924  Millions
60 Degrees Pharmaceuticals Inc   2.13 $ 1.111  Millions$ 0.522  Millions
Cardio Diagnostics Holdings Inc   2.10 $ 0.014  Millions$ 0.007  Millions
Scilex Holding Company  1.93 $ 31.608  Millions$ 16.396  Millions
Ocular Therapeutix Inc   1.79 $ 52.054  Millions$ 29.007  Millions
Heron Therapeutics Inc   1.76 $ 151.507  Millions$ 85.975  Millions
Bio Green Med Solution Inc   1.75 $ 1.861  Millions$ 1.061  Millions
EBR Systems, Inc.  1.74 $ 6.446  Millions$ 3.714  Millions
Cytomx Therapeutics Inc   1.69 $ 18.302  Millions$ 10.821  Millions
Biocorrx Inc   1.67 $ 0.787  Millions$ 0.471  Millions
Prophase Labs Inc   1.59 $ 3.150  Millions$ 1.977  Millions
Amarin Corp Plcuk  1.49 $ 186.480  Millions$ 125.559  Millions
Skinvisible Inc   1.45 $ 0.020  Millions$ 0.014  Millions
Lightwave Logic Inc   1.40 $ 0.250  Millions$ 0.178  Millions
Roivant Sciences Ltd   1.39 $ 7.532  Millions$ 5.400  Millions
Newamsterdam Pharma Company N v   1.15 $ 7.121  Millions$ 6.167  Millions
Clene Inc   1.15 $ 0.197  Millions$ 0.171  Millions
Instil Bio Inc   1.15 $ 8.968  Millions$ 7.822  Millions
Scienture Holdings Inc   1.15 $ 0.821  Millions$ 0.717  Millions
Regen Biopharma Inc   0.99 $ 0.237  Millions$ 0.239  Millions
Prokidney Corp   0.75 $ 0.818  Millions$ 1.088  Millions
Royalty Pharma Plc  0.50 $ 2,535.998  Millions$ 5,116.482  Millions
Cardiff Lexington Corporation  0.46 $ 10.213  Millions$ 22.347  Millions

Date modified: 2026-08-29T02:43:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.